Cushman & Wakefield are pleased to exclusively offer for sale 2 Enterprise Drive, Glendenning, a high-quality industrial facility positioned within one of Sydney's most tightly held and supply-constrained industrial markets.
Offered with vacant possession and supported by a 12-month rental guarantee of $235/sqm plus outgoings, the property presents a compelling opportunity for both investors and owner occupiers. Situated on a prominent 19,480sqm landholding, the asset comprises 9,374sqm of modern warehouse and office accommodation with excellent connectivity to the M7 Motorway, M4 Motorway and broader Western Sydney freight network.
Key Investment Highlights:
- Occupier ready asset - Available with vacant possession, providing immediate flexibility for owner occupiers or investors seeking leasing upside.
- 12-month rental guarantee - Vendor-backed rental guarantee of $2,202,984 p.a. ($235/sqm) plus outgoings, providing immediate income security.
- Prime Western Sydney location - Strategically located within Glendenning, one of Sydney's most tightly held industrial precincts with a vacancy rate of approximately 2.1%.
- Substantial freehold landholding - 19,480sqm freehold site with full drive around access.
- High-quality improvements - Modern industrial facility comprising 9,374sqm of warehouse and office accommodation with ESFR sprinkler systems and full concrete panel construction.
- Strong hardstand provision - Extensive concrete hardstand areas supporting truck circulation, loading operations and vehicle manoeuvrability.
- Superior connectivity - Immediate access to the M7 Motorway, M4 Motorway, Western Sydney Airport and St Marys Intermodal Terminal.
- Strong leasing fundamentals - Positioned within a market characterised by low vacancy, limited future supply and sustained occupier demand.
For sale via an Expressions of Interest campaign, closing Wednesday, 21 October 2026 at 4:00pm (AEDT).
For further information or to arrange an inspection please contact the exclusive marketing agents.
*All figures are approximate.